---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-062952"
form_type: "8-K"
ticker: "RVMD"
cik: "0001628171"
company_name: "Revolution Medicines, Inc."
filed_at: "2023-03-07T23:59:59+00:00"
generated_at: "2026-06-18T09:47:49.172013+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Revolution Medicines closes public offering of 15.7M shares for $323.6M net proceeds

## Summary
- Offering of 15,681,818 shares of common stock at $22.00 per share to the public.
- Underwriters purchased at $20.68 per share; net proceeds of approx. $323.6M.
- Full exercise of underwriters' option; 30-day option period for additional 2M shares.
- Company and insiders subject to 60-day lock-up from prospectus date.
- Lead underwriters: J.P. Morgan, Cowen, SVB Securities, Guggenheim Securities.

## SEC filing metadata
- accession: 0001193125-23-062952
- form_type: 8-K
- ticker: RVMD
- cik: 0001628171
- company_name: Revolution Medicines, Inc.
- filed_at: 2023-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1628171/000119312523062952/0001193125-23-062952-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1628171/000119312523062952/d473040d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-062952
- JSON: https://secwatch.observer/filing/0001193125-23-062952.json
- Plain text: https://secwatch.observer/filing/0001193125-23-062952.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.